Beyond Headlines Into Insight
YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior editor, Liza Laws, Gav Martell, co-founder of Yonalink, shared insights into his journey, the company’s groundbreaking technology, and the promising future of clinical trials. The genesis of Yonalink Gav Martell’s path to Yonalink is a testament to
Read More
This expansion, one of the largest in the company’s history, aims to enhance the production of injectable treatments for obesity and chronic diseases. This investment will create 1.4 million square feet of production space, doubling the footprint of Novo Nordisk’s existing facilities in North Carolina. The new facility will generate 1,000 jobs, in addition to
Read More
Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law, and regulatory policy. The conversation delved into the intricacies of global regulatory practices and the importance of collaboration in the industry. Liza Laws (LL): Thanks for joining me, Ginny. Could you start by introducing yourself and explaining your
Read More
With his background in psychiatry, Michael observed the daily struggles of patients in Opioid Treatment Programs and developed Sonara to offer a more flexible and supportive approach. This groundbreaking solution allows patients to demonstrate responsible methadone use, earn take-home doses faster, and achieve their recovery goals with greater ease. Liza Laws (LL): If you could
Read More
The expansion will introduce 200,000 sq. ft. of additional space, addressing the growing demand for Grade-A facilities amid a rising global appetite for research and development (R&D). The new storage and logistics areas will support over 500 customers, including industry giants such as AstraZeneca, Pfizer, BeiGene, and GE Healthcare. This expansion aligns with Dubai’s strategic
Read More
CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. The platform is designed to streamline processes, improve data integrity, and ensure risk compliance, making clinical trials safer and more efficient. The investment by EQT, a firm with a strong track record in healthcare and technology,
Read More
This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9 September 2023. It introduced a new consolidated framework of standards for computerised systems and electronic data in clinical trials. It is a unique guideline in its thoroughness and extent on the matter. OSP had a conversation with Vesta
Read More
IQVIA recognized the intricate challenges associated with participant payments in clinical trials, which often involve cumbersome processes and multiple vendors, leading to delays and dissatisfaction among participants. Jim provides insights into the motivations and objectives behind launching this comprehensive solution. Can you explain the core motivations behind launching IQVIA’s participant payments service? IQVIA recognized the
Read More
In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for colorectal cancer compares with well known, multicancer blood tests like Galleri. Early detection blood tests such as Grail’s Galleri typically involve isolating DNA from the blood and deploying machine-learning algorithms to scan the DNA for early signs
Read More
The panel featured Ariel Berger, executive director of integrated solutions and real-world evidence at Aventura; John Van Hoy, executive director of AI and advanced analytics at PPD; and Gino Pirro, vice president of product and technology at PPD. The conversation highlighted how AI and real-world data are transforming the landscape of clinical trials. Disease models
Read More